Literature DB >> 8166649

Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis.

M C Field1, S Amatayakul-Chantler, T W Rademacher, P M Rudd, R A Dwek.   

Abstract

The primary structures of the N-linked oligosaccharides from normal human serum IgA1 were determined by a combination of sequential exoglycosidase digestion, Bio-Gel P-4 chromatography, anion-exchange chromatography and one-dimensional n.m.r. spectroscopy. Three major N-linked disialylated biantennary-complex-type structures were found (55%). The remaining N-linked oligosaccharides consisted of at least nine further structures, some of which (7%) were of the triantennary type and included disialylated triantennary oligosaccharides with outer-arm fucose substitution [Fuc alpha 1-3(4)]. Compared with IgG, the N-glycan structures on IgA are more completely processed: the outer arms have a higher proportion of galactose and sialic acid, and only trace levels of incompletely galactosylated oligosaccharides, commonly found on IgG, were detected. Analysis of the sialylated O-glycans revealed that 64% were [NeuAc2 alpha 3(6)]2Gal beta 3GalNAc and 9% were [NeuAc2 alpha 3(6)]-Gal beta 4GlcNAc beta 6[NeuAc2 alpha 3(6)Gal beta 3]GalNAc, and 27% were monosialylated. The N-linked glycosylation of both serum IgA1 and IgG isolated from a group of six normal individuals was compared with that from ten patients with rheumatoid arthritis (RA). In contrast with the hypogalactosylation found in IgG from diseased sera, there was no evidence of an equivalent decrease in the galactosylation of the IgA1 oligosaccharides. In addition, the N-glycosylation of IgA1 was remarkably consistent within the group of normal individuals. These data suggest that incomplete galactosylation of N-linked glycans and its augmentation in RA does not extend to IgA1 and that the RA-associated galactosyltransferase deficiency may be restricted to cells producing gamma-chain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166649      PMCID: PMC1138050          DOI: 10.1042/bj2990261

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

1.  Immunoglobulin G as a glycoprotein.

Authors:  T W Rademacher; S W Homans; R B Parekh; R A Dwek
Journal:  Biochem Soc Symp       Date:  1986

Review 2.  Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides.

Authors:  H Schachter
Journal:  Biochem Cell Biol       Date:  1986-03       Impact factor: 3.626

3.  Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis.

Authors:  I B Wilson; F M Platt; D A Isenberg; T W Rademacher
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

4.  Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.

Authors:  G R Yeaman; M A Kerr
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

5.  Activation of the alternative pathway of complement by human serum IgA.

Authors:  P S Hiemstra; A Gorter; M E Stuurman; L A Van Es; M R Daha
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

6.  Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G.

Authors:  N Takahashi; I Ishii; H Ishihara; M Mori; S Tejima; R Jefferis; S Endo; Y Arata
Journal:  Biochemistry       Date:  1987-02-24       Impact factor: 3.162

7.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

Authors:  R B Parekh; R A Dwek; B J Sutton; D L Fernandes; A Leung; D Stanworth; T W Rademacher; T Mizuochi; T Taniguchi; K Matsuta
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

8.  The regulation of glycan processing in glycoproteins. The effect of avidin on individual steps in the processing of biotinylated glycan derivatives.

Authors:  M C Shao; C C Chin; R M Caprioli; F Wold
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

9.  The beta 1----2-D-xylose and alpha 1----3-L-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin. Isolation, characterisation and comparison with other legume lectins.

Authors:  D Ashford; R A Dwek; J K Welply; S Amatayakul; S W Homans; H Lis; G N Taylor; N Sharon; T W Rademacher
Journal:  Eur J Biochem       Date:  1987-07-15

Review 10.  Network theory of glycosylation--etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity.

Authors:  T W Rademacher
Journal:  Semin Cell Biol       Date:  1991-10
View more
  30 in total

1.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

Authors:  Altan Ercan; Jing Cui; Dereck E W Chatterton; Kevin D Deane; Melissa M Hazen; William Brintnell; Colin I O'Donnell; Lezlie A Derber; Michael E Weinblatt; Nancy A Shadick; David A Bell; Ewa Cairns; Daniel H Solomon; V Michael Holers; Pauline M Rudd; David M Lee
Journal:  Arthritis Rheum       Date:  2010-08

2.  Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.

Authors:  Michelle M Gomes; Hitoshi Suzuki; Monica T Brooks; Milan Tomana; Zina Moldoveanu; Jiri Mestecky; Bruce A Julian; Jan Novak; Andrew B Herr
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

3.  Characterization of a plant-produced recombinant human secretory IgA with broad neutralizing activity against HIV.

Authors:  Matthew Paul; Rajko Reljic; Katja Klein; Pascal M W Drake; Craig van Dolleweerd; Martin Pabst; Markus Windwarder; Elsa Arcalis; Eva Stoger; Friedrich Altmann; Catherine Cosgrove; Angela Bartolf; Susan Baden; Julian K-C Ma
Journal:  MAbs       Date:  2014       Impact factor: 5.857

4.  FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.

Authors:  Monica T Posgai; Sam Tonddast-Navaei; Manori Jayasinghe; George M Ibrahim; George Stan; Andrew B Herr
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

5.  Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.

Authors:  Martin Svoboda; Benjamin F Mann; John A Goetz; Milos V Novotny
Journal:  Anal Chem       Date:  2012-03-13       Impact factor: 6.986

6.  Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines.

Authors:  Esther M Yoo; Li J Yu; Letitia A Wims; David Goldberg; Sherie L Morrison
Journal:  MAbs       Date:  2010-05-17       Impact factor: 5.857

7.  Aberrant glycosylation of IgA from patients with IgA nephropathy.

Authors:  D Baharaki; M Dueymes; R Perrichot; C Basset; R Le Corre; J Clèdes; P Youinou
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

8.  Evidence for a site-specific fucosylation of N-linked oligosaccharide of immunoglobulin A1 from normal human serum.

Authors:  A Tanaka; H Iwase; Y Hiki; T Kokubo; I Ishii-Karakasa; K Toma; Y Kobayashi; K Hotta
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

9.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Authors:  Michelle M Gomes; Stephanie B Wall; Kazuo Takahashi; Jan Novak; Matthew B Renfrow; Andrew B Herr
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.